![A conversation about clinical trials with Ruben Mesa and Naveen Pemmaraju](https://oncodaily.com/pub/uploads/2024/09/IMG_4822.jpg)
A conversation about clinical trials with Ruben Mesa and Naveen Pemmaraju
Ruben Mesa shared a post on LinkedIn:
”Excited to share in a patient focused discussion on cancer clinical trials with my friend Naveen Pemmaraju at the MPN Advocacy patient meeting in Asheville, North Carolina at the Atrium Health Wake Forest Baptist Comprehensive Cancer Center.”
Source: Ruben Mesa/LinkedIn
Ruben Mesa, MD, FACP, serves as the president and executive director of Atrium Health Levine Cancer Institute (LCI) and Atrium Health Wake Forest Baptist Comprehensive Cancer Center. Additionally, he holds the position of vice dean for cancer programs and professor of medicine at Wake Forest University School of Medicine. He is an international expert in hematologic cancers, particularly myeloproliferative neoplasms (MPNs). Through his tireless efforts, Dr. Mesa continues to drive progress in the understanding and treatment of hematologic malignancies, offering hope to those affected by these complex diseases.
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023